Prediction and management of bleeding in cardiac surgery

摘要: Excessive bleeding after cardiac surgery can result in increased morbidity and mortality related to transfusion- hypoperfusion-related injuries critical organ systems. Our objective was review mechanisms that as well current emerging interventions reduce transfusion. We discovered of point-of-care (POC) tests hemostatic function facilitate the optimal management excessive transfusion by facilitating administration specific pharmacologic or transfusion-based therapy allowing physicians better differentiate between microvascular surgical bleeding. Emerging like recombinant FVIIa have potential transfusion-related sequelae may be life-saving; however, randomized, controlled trials are needed confirm safety before they used either first-line therapies for prophylaxis. In conclusion, careful investigation role new is essential ability use blood products, decrease operative time and/or re-exploration rates has important implications overall patient health care costs.